264 related articles for article (PubMed ID: 9858246)
1. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel.
Hechler B; Eckly A; Ohlmann P; Cazenave JP; Gachet C
Br J Haematol; 1998 Dec; 103(3):858-66. PubMed ID: 9858246
[TBL] [Abstract][Full Text] [Related]
2. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
3. The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.
Hechler B; Léon C; Vial C; Vigne P; Frelin C; Cazenave JP; Gachet C
Blood; 1998 Jul; 92(1):152-9. PubMed ID: 9639511
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
Jin J; Daniel JL; Kunapuli SP
J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
[TBL] [Abstract][Full Text] [Related]
5. Role of P2Y1 purinoceptor in ADP-induced platelet activation.
Savi P; Beauverger P; Labouret C; Delfaud M; Salel V; Kaghad M; Herbert JM
FEBS Lett; 1998 Feb; 422(3):291-5. PubMed ID: 9498802
[TBL] [Abstract][Full Text] [Related]
6. Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP.
Contreres JO; Dupuy E; Job B; Habib A; Bryckaert M; Rosa JP; Simoneau G; Herbert JM; Savi P; Levy-Toledano S
Br J Haematol; 2003 Feb; 120(4):633-42. PubMed ID: 12588350
[TBL] [Abstract][Full Text] [Related]
7. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors.
Gachet C; Cattaneo M; Ohlmann P; Hechler B; Lecchi A; Chevalier J; Cassel D; Mannucci PM; Cazenave JP
Br J Haematol; 1995 Oct; 91(2):434-44. PubMed ID: 8547091
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation by ADP: the role of ADP antagonists.
Gachet C
Ann Med; 2000 Dec; 32 Suppl 1():15-20. PubMed ID: 11209975
[TBL] [Abstract][Full Text] [Related]
9. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
[TBL] [Abstract][Full Text] [Related]
10. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
Packham MA; Mustard JF
Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
[TBL] [Abstract][Full Text] [Related]
11. P2Y12, a new platelet ADP receptor, target of clopidogrel.
Herbert JM; Savi P
Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
[TBL] [Abstract][Full Text] [Related]
12. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
Savi P; Herbert JM
Semin Thromb Hemost; 2005 Apr; 31(2):174-83. PubMed ID: 15852221
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors.
Paul BZ; Jin J; Kunapuli SP
J Biol Chem; 1999 Oct; 274(41):29108-14. PubMed ID: 10506165
[TBL] [Abstract][Full Text] [Related]
14. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
Savi P; Laplace MC; Maffrand JP; Herbert JM
J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW
Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834
[TBL] [Abstract][Full Text] [Related]
16. Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel.
Geiger J; Brich J; Hönig-Liedl P; Eigenthaler M; Schanzenbächer P; Herbert JM; Walter U
Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):2007-11. PubMed ID: 10446085
[TBL] [Abstract][Full Text] [Related]
17. ADP receptor induced activation of guanine nucleotide binding proteins in rat platelet membranes--an effect selectively blocked by the thienopyridine clopidogrel.
Gachet C; Savi P; Ohlmann P; Maffrand JP; Jakobs KH; Cazenave JP
Thromb Haemost; 1992 Jul; 68(1):79-83. PubMed ID: 1514178
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
Weber AA; Reimann S; Schrör K
Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
[TBL] [Abstract][Full Text] [Related]
19. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation.
Jantzen HM; Gousset L; Bhaskar V; Vincent D; Tai A; Reynolds EE; Conley PB
Thromb Haemost; 1999 Jan; 81(1):111-7. PubMed ID: 10348701
[TBL] [Abstract][Full Text] [Related]
20. The P2 receptors and congenital platelet function defects.
Cattaneo M
Semin Thromb Hemost; 2005 Apr; 31(2):168-73. PubMed ID: 15852220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
